Versant Vantage I GP, L.P.'s Net Worth
Estimate Recalculated Nov 1, 2024 11:31AM EST
Who is Versant Vantage I GP, L.P.
Versant Vantage I GP, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Repare Therapeutics Inc., Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., Pandion Therapeutics Holdco LLC, Passage BIO, Inc., RayzeBio, Inc., Aprea Therapeutics, Inc., and Contineum Therapeutics, Inc..
SEC CIK
Versant Vantage I GP, L.P.'s CIK is 0001777651
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
